» Articles » PMID: 15632293

Regulatory Mechanisms and Function of ERK MAP Kinases

Overview
Journal J Biochem
Specialty Biochemistry
Date 2005 Jan 6
PMID 15632293
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Spatiotemporal control of the Ras/ERK MAP kinase signaling pathway is a key factor for determining the specificity of cellular responses including cell proliferation, cell differentiation and cell survival. The fidelity of this signaling is regulated by docking interactions as well as scaffolding. Subcellular localization of ERK is controlled by cytoplasmic ERK anchoring proteins that have a nuclear export signal (NES), such as MEK. In quiescent cells, ERK and MEK localize to the cytoplasm. In response to stimulation, dissociation of the MEK-ERK complex is induced and activated ERK translocates to the nucleus. Recently, several negative regulators for Ras/ERK signaling have been identified and their detailed molecular mechanisms have been analyzed. Among them, Sprouty and Sef act as a temporal and a spatial regulator, respectively, for Ras/ERK signaling. Thus, multiple factors are involved in control of Ras/ERK signaling.

Citing Articles

Magnetically Stimulated Myogenesis Recruits a CRY2-TRPC1 Photosensitive Signaling Axis.

Iversen J, Tai Y, Wu K, Wong C, Lim H, Franco-Obregon A Cells. 2025; 14(3).

PMID: 39937022 PMC: 11817702. DOI: 10.3390/cells14030231.


Investigation of the Molecular Mechanisms Underlying the Antiatherogenic Actions of Kaempferol in Human THP-1 Macrophages.

Huwait E, Ayoub M, Karim S Int J Mol Sci. 2022; 23(13).

PMID: 35806463 PMC: 9267302. DOI: 10.3390/ijms23137461.


Phosphoinositide 3-kinase/Akt and its related signaling pathways in the regulation of tumor-associated macrophages polarization.

Yang D, Yang L, Cai J, Li H, Xing Z, Hou Y Mol Cell Biochem. 2022; 477(10):2469-2480.

PMID: 35590082 DOI: 10.1007/s11010-022-04461-w.


Proteomic Changes in the Monolayer and Spheroid Melanoma Cell Models of Acquired Resistance to BRAF and MEK1/2 Inhibitors.

Martinez 3rd R, Huang W, Buck H, Rea S, Defnet A, Kane M ACS Omega. 2022; 7(4):3293-3311.

PMID: 35128241 PMC: 8811929. DOI: 10.1021/acsomega.1c05361.


ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer.

Sugiura R, Satoh R, Takasaki T Cells. 2021; 10(10).

PMID: 34685488 PMC: 8533760. DOI: 10.3390/cells10102509.